Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer

Scandinavian Journal of Gastroenterology

Volumn 40, Issue 1, 2005, Pages 56-60

  Pérez Pérez, Guillermo Ignacio ^a   Bosques Padilla, Francisco Javier ^b   Crosatti, Maria Luisa ^a   Tijerina Menchaca, Rolando ^c   Garza González, Elvira ^c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

^c Medicina UANL   (Mexico)

Author keywords

Arg Arg; Arg Pro; Codon 72; Gastric cancer; Helicobacter; p53; Polymorphism; Pro Pro

Indexed keywords

ARGININE; PROLINE;

ADULT; ALLELE; ARTICLE; ATROPHIC GASTRITIS; CODON; CONFIDENCE INTERVAL; EXON; FEMALE; GASTROINTESTINAL ENDOSCOPY; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; MEXICO; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE; STOMACH CANCER; TUMOR SUPPRESSOR GENE; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; CODON; CONFIDENCE INTERVALS; FEMALE; GASTROSCOPY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MEXICO; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROBABILITY; PROGNOSIS; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 12444315955     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520410009456     Document Type: Article

References (21)

1. Lane DP. P53 guardian of the genome. Nature 1992;358: 15-6.
2. Wynford-Thomas D, Blaydes J. The influence of cell context on the selection pressure for p53 mutation in human cancer. Carcinogenesis 1998;19:29-36.
3. Ara S, Lee PS, Hansen MF, Saya H. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 1990;18:4961.
4. Walker KK, Levine AJ. Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA 1996;93:15335-40.
5. Fan R, Wu M, Miller D, Wain JC, Kelsey KT, Wiencke JK, et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:1037-42.
6. Sifuentes Alvarez A, Reyes Romero M. Risk factors for cervico-uterine cancer associated to HPV:p53 codon 72 polymorphism in women attending hospital care. Ginecol Obstet Mex 2003;71:12-5.
7. Zhang ZW, Newcomb P, Hollowood A, Feakins R, Moorghen M, Storey A, et al. Age-associated increase of codon 72 arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res 2003;9:2151-6.
8. Hiyama T, Tanaka S, Kitadai Y, Ito M, Sumii M, Yoshihara M, et al. p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer 2002;100:304-8.
9. Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, et al. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology 2000;118: 1039-44.
10. Anzola M, Cuevas N, Lopez-Martinez M, Saiz A, Burgos JJ, de Pancorbo MM. Frequent loss of p53 codon 72 Pro variant in hepatitis C virus-positive carriers with hepatocellular carcinoma. Cancer Lett 2003;193:199-205.
11. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 1999;29:697-702.
12. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998;393:229-34.
13. Murata M, Tagawa M, Kimura M, Kimura H, Watanabe S, Saisho H. Analysis of a germ line polymorphism of the p53 gene in lung cancer patients; discrete results with smoking history. Carcinogenesis 1996;17:261-4.
14. Buyru N, Tigli H, Dalay N. P53 codon 72 polymorphism in breast cancer. Oncol Rep 2003;10:711-4.
15. Zhang ZW, Laurence NJ, Hollowood A, Newcomb P, Moorghen M, Gupta J, et al. Prognostic value of TP53 codon 72 polymorphism in advanced gastric adenocarcinoma. Clin Cancer Res 2004;10:131-5.
16. Zhang ZW, Newcomb P, Hollowood A, Feakins R, Moorghen M, Storey A, et al. Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res 2003;9:2151-6.
17. Sun Y, Keshava C, Sharp DS, Weston A, McCanlies EC. DNA sequence variants of p53: cancer and aging. Am J Hum Genet 1999;65:1779-82.
18. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999;19:1092-100.
19. Sakamuro D, Sabbatini P, White E, Prendergast GC. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 1997;15:887-98.
20. Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 2001;96:16-26.
21. Beckman G, Birgander R, Sjalander A, Saha N, Holmberg PA, Kivela A, et al. Is p53 polymorphism maintained by natural selection? Hum Hered 1994;44:266-70.